ARAY - Accuray Inc Stock Price, Fair Value and News

1.92USD+0.05 (+2.67%)Market Closed

Market Summary

USD1.92+0.05

Market Closed

2.67%

ARAY Stock Price

View Fullscreen

ARAY RSI Chart

ARAY Valuation

Market Cap

190.5M

Price/Earnings (Trailing)

-8.87

Price/Sales (Trailing)

0.44

EV/EBITDA

-690.78

Price/Free Cashflow

-7.91

ARAY Price/Sales (Trailing)

ARAY Profitability

Operating Margin

33.01%

EBT Margin

-4.10%

Return on Equity

-52.31%

Return on Assets

-4.65%

Free Cashflow Yield

-12.64%

ARAY Fundamentals

ARAY Revenue

Revenue (TTM)

430.6M

Rev. Growth (Yr)

-14.34%

Rev. Growth (Qtr)

-5.69%

ARAY Earnings

Earnings (TTM)

-21.5M

Earnings Growth (Yr)

-1.2K%

Earnings Growth (Qtr)

34.08%

Breaking Down ARAY Revenue

Last 7 days

6.7%

Last 30 days

7.3%

Last 90 days

-12.3%

Trailing 12 Months

-52.4%

How does ARAY drawdown profile look like?

ARAY Financial Health

Current Ratio

1.58

Debt/Equity

4.05

Debt/Cashflow

-0.08

ARAY Investor Care

Shares Dilution (1Y)

3.65%

Diluted EPS (TTM)

-0.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	430.6M	0	0	0
2023	439.3M	447.6M	455.0M	447.5M
2022	430.8M	429.9M	419.0M	417.4M
2021	380.3M	396.3M	418.4M	437.2M
2020	405.4M	382.9M	378.7M	377.3M
2019	415.3M	418.8M	413.9M	409.0M
2018	403.2M	404.9M	408.4M	411.8M
2017	366.3M	383.4M	387.9M	400.7M
2016	405.6M	398.8M	395.7M	374.3M
2015	380.1M	379.8M	387.1M	397.8M
2014	352.3M	369.4M	375.2M	379.7M
2013	331.6M	316.0M	309.9M	325.7M
2012	383.9M	409.2M	391.5M	362.9M
2011	222.1M	222.3M	284.7M	336.8M
2010	0	221.6M	221.8M	222.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

CEO	Ms. Suzanne Winter M.B.A.
WEBSITE	accuray.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1024

Accuray Inc Frequently Asked Questions

What is the ticker symbol for Accuray Inc? What does ARAY stand for in stocks?

ARAY is the stock ticker symbol of Accuray Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Accuray Inc (ARAY)?

As of Fri Jul 26 2024, market cap of Accuray Inc is 190.55 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ARAY stock?

You can check ARAY's fair value in chart for subscribers.

Is Accuray Inc a good stock to buy?

The fair value guage provides a quick view whether ARAY is over valued or under valued. Whether Accuray Inc is cheap or expensive depends on the assumptions which impact Accuray Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ARAY.

What is Accuray Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, ARAY's PE ratio (Price to Earnings) is -8.87 and Price to Sales (PS) ratio is 0.44. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ARAY PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Accuray Inc's stock?

In the past 10 years, Accuray Inc has provided -0.134 (multiply by 100 for percentage) rate of return.